Registered Trials

• NCT05415267

  Phase 3

  Australia

  Total Enrollment: 320

  Official Trial Registration:

  • NCT05415267(Opens in new tab/window)

• NCT05405283

  Phase 3

  France

  Total Enrollment: 178

  Official Trial Registration:

  • NCT05405283(Opens in new tab/window)

• NCT05124171, EUCTR2021-004550-33

  Phase 3

  France

  Total Enrollment: 300

  Official Trial Registration:

  • NCT05124171(Opens in new tab/window)
  • EUCTR2021-004550-33(Opens in new tab/window)

• NCT05329220

  Phase 3

  Total Enrollment: 4,000

  Official Trial Registration:

  • NCT05329220(Opens in new tab/window)

• NCT05293665

  Phase 3

  United States of America

  Total Enrollment: 1,010

  Official Trial Registration:

  • NCT05293665(Opens in new tab/window)

• NCT05387317

  Phase 3

  Indonesia

  Total Enrollment: 800

  Official Trial Registration:

  • NCT05387317(Opens in new tab/window)

• NCT05142319

  Phase 3

  Singapore

  Total Enrollment: 600

  Official Trial Registration:

  • NCT05142319(Opens in new tab/window)

• NCT05228730

  Phase 3

  Australia

  Total Enrollment: 800

  Official Trial Registration:

  • NCT05228730(Opens in new tab/window)

• NCT04805125

  Phase 3

  Switzerland

  Total Enrollment: 380

  Official Trial Registration:

  • NCT04805125(Opens in new tab/window)

• NCT04800133

  Phase 3

  Hong Kong

  Total Enrollment: 900

  Official Trial Registration:

  • NCT04800133(Opens in new tab/window)

• NCT05225285

  Phase 3

  Brazil

  Total Enrollment: 1,120

  Official Trial Registration:

  • NCT05225285(Opens in new tab/window)

• NCT05029245

  Phase 3

  Total Enrollment: 1,000

  Official Trial Registration:

  • NCT05029245(Opens in new tab/window)

• NCT05265065

  Phase 3

  Mongolia

  Total Enrollment: 800

  Official Trial Registration:

  • NCT05265065(Opens in new tab/window)

• NCT05047640

  Phase 3

  United States of America

  Total Enrollment: 200

  Official Trial Registration:

  • NCT05047640(Opens in new tab/window)

• NCT04816669

  Phase 3

  United States of America

  Total Enrollment: 550

  Official Trial Registration:

  • NCT04816669(Opens in new tab/window)

• NCT04951323

  Phase 3

  Belgium

  Total Enrollment: 50

  Official Trial Registration:

  • NCT04951323(Opens in new tab/window)

• NCT04713553

  Phase 3

  United States of America

  Total Enrollment: 1,530

  Official Trial Registration:

  • NCT04713553(Opens in new tab/window)

• NCT04368728, EUCTR2020-002641-42

  Phase 2/3

  Argentina, Brazil, Germany, South Africa, Turkey, United States of America

  Total Enrollment: 43,998

  Official Trial Registration:

  • NCT04368728(Opens in new tab/window)
  • EUCTR2020-002641-42(Opens in new tab/window)

• NCT05354024

  Phase 2/3

  Brazil

  Total Enrollment: 4,400

  Official Trial Registration:

  • NCT05354024(Opens in new tab/window)

• jRCT2031210470

  Phase 2/3

  Japan

  Total Enrollment: 204

  Official Trial Registration:

  • jRCT2031210470(Opens in new tab/window)

• NCT05022329

  Phase 2/3

  Canada

  Total Enrollment: 300

  Official Trial Registration:

  • NCT05022329(Opens in new tab/window)

• NCT04754594

  Phase 2/3

  United States of America

  Total Enrollment: 4,000

  Official Trial Registration:

  • NCT04754594(Opens in new tab/window)

• NCT05308602

  Phase 2

  Total Enrollment: 480

  Official Trial Registration:

  • NCT05308602(Opens in new tab/window)

• NCT05329051

  Phase 2

  Total Enrollment: 400

  Official Trial Registration:

  • NCT05329051(Opens in new tab/window)

• NCT05004181

  Phase 2

  Germany, South Africa, Turkey, United States of America

  Total Enrollment: 1,245

  Official Trial Registration:

  • NCT05004181(Opens in new tab/window)

• NCT05238441

  Phase 2

  Total Enrollment: 360

  Official Trial Registration:

  • NCT05238441(Opens in new tab/window)

• NCT05239975

  Phase 2

  Total Enrollment: 240

  Official Trial Registration:

  • NCT05239975(Opens in new tab/window)

• NCT05238454

  Phase 2

  Total Enrollment: 600

  Official Trial Registration:

  • NCT05238454(Opens in new tab/window)

• NCT04949490

  Phase 2

  Germany

  Total Enrollment: 549

  Official Trial Registration:

  • NCT04949490(Opens in new tab/window)

• NCT05142514

  Phase 2

  Viet Nam

  Total Enrollment: 256

  Official Trial Registration:

  • NCT05142514(Opens in new tab/window)

• NCT05142553

  Phase 2

  Spain

  Total Enrollment: 1,075

  Official Trial Registration:

  • NCT05142553(Opens in new tab/window)

• EUCTR2022-000795-19

  Phase 2

  Spain

  Total Enrollment: 273

  Official Trial Registration:

  • EUCTR2022-000795-19(Opens in new tab/window)

• NCT05305573

  Phase 2

  Spain

  Total Enrollment: 273

  Official Trial Registration:

  • NCT05305573(Opens in new tab/window)

• ISRCTN73765130

  Phase 2

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 2,664

  Official Trial Registration:

  • ISRCTN73765130(Opens in new tab/window)

• NCT05324319

  Phase 2

  Austria

  Total Enrollment: 200

  Official Trial Registration:

  • NCT05324319(Opens in new tab/window)

• NCT05000216

  Phase 2

  United States of America

  Total Enrollment: 2,340

  Official Trial Registration:

  • NCT05000216(Opens in new tab/window)

• NCT05077254

  Phase 2

  United States of America

  Total Enrollment: 400

  Official Trial Registration:

  • NCT05077254(Opens in new tab/window)

• NCT04894435

  Phase 2

  Canada

  Total Enrollment: 1,300

  Official Trial Registration:

  • NCT04894435(Opens in new tab/window)

• NCT04761822

  Phase 2

  United States of America

  Total Enrollment: 3,400

  Official Trial Registration:

  • NCT04761822(Opens in new tab/window)

• NCT04969263

  Phase 2

  United States of America

  Total Enrollment: 200

  Official Trial Registration:

  • NCT04969263(Opens in new tab/window)

• EUCTR2021-002348-57

  Phase 2

  Austria

  Total Enrollment: 60

  Official Trial Registration:

  • EUCTR2021-002348-57(Opens in new tab/window)

• NCT04992182

  Phase 2

  Chile

  Total Enrollment: 534

  Official Trial Registration:

  • NCT04992182(Opens in new tab/window)

• NCT05049226

  Phase 2

  Thailand

  Total Enrollment: 1,320

  Official Trial Registration:

  • NCT05049226(Opens in new tab/window)

• TCTR20211027002

  Phase 2

  Thailand

  Total Enrollment: 200

  Official Trial Registration:

  • TCTR20211027002(Opens in new tab/window)

• NCT04977479

  Phase 2

  United States of America

  Total Enrollment: 100

  Official Trial Registration:

  • NCT04977479(Opens in new tab/window)

• NCT05378191, NCT04860739, EUCTR2021-001978-37

  Phase 2

  Spain

  Total Enrollment: 600

  Official Trial Registration:

  • NCT05378191(Opens in new tab/window)
  • NCT04860739(Opens in new tab/window)
  • EUCTR2021-001978-37(Opens in new tab/window)

• NCT04907331

  Phase 2

  Austria

  Total Enrollment: 3,000

  Official Trial Registration:

  • NCT04907331(Opens in new tab/window)

• NCT04824638

  Phase 2

  France

  Total Enrollment: 300

  Official Trial Registration:

  • NCT04824638(Opens in new tab/window)

• NCT04895982

  Phase 2

  Brazil, Germany, United States of America

  Total Enrollment: 360

  Official Trial Registration:

  • NCT04895982(Opens in new tab/window)

• EUCTR2021-005043-71

  Phase 2

  Netherlands

  Total Enrollment: 400

  Official Trial Registration:

  • EUCTR2021-005043-71(Opens in new tab/window)

• ISRCTN69254139

  Phase 2

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 820

  Official Trial Registration:

  • ISRCTN69254139(Opens in new tab/window)

• NCT04649021

  Phase 2

  China

  Total Enrollment: 950

  Official Trial Registration:

  • NCT04649021(Opens in new tab/window)

• jRCT2071210106

  Phase 1/2/3

  Japan

  Total Enrollment: 5,028

  Official Trial Registration:

  • jRCT2071210106(Opens in new tab/window)

• EUCTR2020-005442-42

  Phase 1/2/3

  Finland, Poland, Spain, United States of America

  Total Enrollment: 4,644

  Official Trial Registration:

  • EUCTR2020-005442-42(Opens in new tab/window)

• NCT05370040

  Phase 1/2

  South Africa

  Total Enrollment: 180

  Official Trial Registration:

  • NCT05370040(Opens in new tab/window)

• NCT05231369

  Phase 1/2

  Thailand

  Total Enrollment: 60

  Official Trial Registration:

  • NCT05231369(Opens in new tab/window)

• NCT04889209

  Phase 1/2

  United States of America

  Total Enrollment: 400

  Official Trial Registration:

  • NCT04889209(Opens in new tab/window)

• EUCTR2020-001038-36, NCT04380701

  Phase 1/2

  Germany

  Total Enrollment: 456

  Official Trial Registration:

  • EUCTR2020-001038-36(Opens in new tab/window)
  • NCT04380701(Opens in new tab/window)

• NCT05132855

  Phase 1/2

  Taiwan

  Total Enrollment: 400

  Official Trial Registration:

  • NCT05132855(Opens in new tab/window)

• TCTR20220330001

  Phase 1/2

  Thailand

  Total Enrollment: 60

  Official Trial Registration:

  • TCTR20220330001(Opens in new tab/window)

• TCTR20211102006

  Phase 1/2

  Thailand

  Total Enrollment: 105

  Official Trial Registration:

  • TCTR20211102006(Opens in new tab/window)

• NCT04969601

  Phase 1/2

  France

  Total Enrollment: 150

  Official Trial Registration:

  • NCT04969601(Opens in new tab/window)

• NCT04588480

  Phase 1/2

  Japan

  Total Enrollment: 160

  Official Trial Registration:

  • NCT04588480(Opens in new tab/window)

• NCT05394012

  Phase 1

  Total Enrollment: 120

  Official Trial Registration:

  • NCT05394012(Opens in new tab/window)

• NCT04839315

  Phase 1

  United States of America

  Total Enrollment: 100

  Official Trial Registration:

  • NCT04839315(Opens in new tab/window)

• NCT04816643

  Phase 1

  United States of America

  Total Enrollment: 4,644

  Official Trial Registration:

  • NCT04816643(Opens in new tab/window)

• NCT04936997

  Phase 1

  United States of America

  Total Enrollment: 1,000

  Official Trial Registration:

  • NCT04936997(Opens in new tab/window)